Archive | Macro

Biotech Bear Market Update: Barely Bouncing Off the Bottom

Have we reached a tradeable bottom in the biotech bear market? Today’s tape showed good volume but gains faded late in session. NASDAQ up 0.35%         XLV up 0.88%-healthcare is the leading sector The biotech market bounced back early today in a broad rally then faded with the IBB up 0.625 % […]

Continue Reading 0

Nasty Day With Big Sell-Off in Healthcare and Biotech

Biotech Sell-Off Stops Bear Market Rally After a strong November and a rally from October lows biotech stocks broke down today along with the overall market. Keep in mind that it has been a bear market rally with expectations of a seasonal move up. There are plenty of possible reasons for the market weakness both […]

Continue Reading 0

Biotech Stocks Sell-Off on China, Greece and Network Outages…Update-1 Rally Mode

7/13/15 12N EDT Roller Coaster Market MACRO to sidelines A wave of optimism reverses concerns about China and Greece. China stocks have recovered because there is still growth potential. Although a Greek deal is not finalized the glass is half full again and a Grexit looks off the table. Apparently any Greek deal is a […]

Continue Reading 0

Biotech Stocks Shake Off Fears of Greek Crisis…Update-1… 7/8

Update 7/8/15  12:10p EDT Strange Day with Computer Networks NYSE exchange is down and trading halted- all orders are cancelled. However stocks are trading on other exchanges but at very low volume. United Airlines Grounding Ends after two hour disruption due to a router issue. Apparently no connection but….some other WEB sites are down as well. e.g. […]

Continue Reading 0

What Sell-Off? Biotechs Cruise: CLVS, SGEN

Stocks in Sharp Sell-Off on Potential FED Rate Increase and Strong Dollar Deflation is Still Lurking S&P Down 1.7%, NASDAQ down 1.67% Biotech stocks avoided the severe sell-off today apparently immune to the strong dollar, flat earnings growth and FED interest rate concerns. Although life science stocks were mixed the bellwether ETFs held their ground: […]

Continue Reading 0

MOmentum Shift in BIOtech Today: XBI off 3.25%.. Update -1

Update Next Day…Green Screen in Biotech…1/16…Complete reversal all up XBI at $197.95 UP 3% AGIO up 3.6%, BLUE up 4.78%, JUNO up 12.4%, KITE up 10.2%, NLNK up 2.4%, PBYI up 9.4%, ZIOP up 1.76% Red Screen Day in Biotech NASDAQ 4584 down 1.18%    Euro down to $1.16     Gold at $1262 up […]

Continue Reading 0

2015 Biotech Stock Preview: Rhythms of the “PermaBull”

2015: Another Good Year Unless “Something Happens” Life Science stocks had another big year in 2014 up 48% tracking gains for the overall healthcare sector up 35%. Over 10 years the return is 300%! The move up was not a straight line as there were  two major corrections in April 2014 after the Q1 “bio-bubble” […]

Continue Reading 0

Biotechs Avoid Harsh Sell-Off: Many Stocks in the Green

XLE off 4%, NASDAQ Off 1.57%, Biotech Mainly In The Green After Close: Financials and Materials also hit hard down over 2% Biotech stocks remain a safe harbor in a stormy market freaked out by the energy free-fall. Most major biotech ETFs are up FBT,XBI but the IBB was a little volatile eventually off 0.16%.KITE […]

Continue Reading 0

Sentiment Shift in a Wild Week: Biotech Bull Is Back-JUNO IPO Up 45%!… Update-1

Biotech Stocks Rally to New Highs After 4% Correction Buyers Are Bottom Feeding Energy Stocks NASDAQ at 4765 Just as the market appeared to be headed to another test of October lows, challenged by news on slowing global growth and a collapsing energy sector, FED Chair Janet Yellen calmed the markets saying it would be […]

Continue Reading 0

Sierra SnowBlog Dec.10: Big Storm Is Coming Update-2, Winter Climate Update

12/23 Dry Period Ahead for the West After Little “Slider” Storm This Week 96f.gif 1,024×768 pixels Mammoth Lakes Weather brought to you by Howard Sheckter We may need to wait for an El Nino to kick in because we have a dry period ahead. Luckily we got some PPT last week. Climate Prediction Center – […]

Continue Reading 0

Energy Weakness Rolls Over To Biotech Stocks Update-1… 12/12

Crude Trade Roils Markets-But Biotech Is Still A Safe Haven Second Worst Week of the Year-Late Day Trading Hit By Selling As the market becomes more volatile we should look at how the energy trade is affecting other asset classes. Certainly materials and industrials are being hit over the past month. With respect to healthcare […]

Continue Reading 0

Trading A Bottom in Small Cap Life Science Stocks …Update 11/5

11/15/14  Speculative Small Cap Stocks-Stay Away Unless Your Are A Trader Nice profits were booked on our recent small cap picks but today the sell-off was “pronounced”: Celldex (CLDX) was down 21% to $13.10 after hitting a high near $18 on October 31. GlycoMimetics (GLYC) was up 2.14% to $7.62 more than 15% above our […]

Continue Reading 0

Technical Damage to Market is Significant: Fear Factor Rules..Update 10/14

10/14 …Update 3:10p Here come the sellers late in the day on schedule. Investors are trying to hold the fort. Oil down, treasuries up, JPMorgan misses off 0.43%. XLE off 0.57%, Gold steady at 1233, biotechs mixed but GILD down 5%, industrials and technology in the green. Germany slashes growth forecast. FINVIZ.com – Stock Screener […]

Continue Reading 0

BIO Investor Forum Oct. 7-8, 2014: #1 How Fragile is the Biotech Rally?

Five Year Bull Market in Biotech  We attended the Bio Investor Forum in San Francisco this week and it was well attended with over 600 participants and over 120 companies presenting. Attendees included VCs , investors, industry executives, bankers, and media. The Bio Investor Forum is one of the best meetings for current issues and […]

Continue Reading 0

BABA Open Indication at $92-93: NASDAQ In RED… Update-1

Alibaba Should Open by 12 N EDT at $92.70, well above $68 IPO Price Price Discovery Underway with Trades moving toward $100 but now selling off to $93 up 36%. Alibaba (BABA) group may be sucking up a lot of cash from NASDAQ trades even with a option expiration. Money keeps flowing in as NYSE […]

Continue Reading 0